Advertisement

Index by author

June 01, 2015; Volume 353,Issue 3

  1. Li, Shan

    1. A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor γ with Excellent Effect on Insulin Resistance and Type 2 Diabetes
      Hui-juan Liu, Cheng-yu Zhang, Fei Song, Ting Xiao, Jing Meng, Qiang Zhang, Cai-li Liang, Shan Li, Jing Wang, Bo Zhang, Yan-rong Liu, Tao Sun and Hong-gang Zhou
      Journal of Pharmacology and Experimental Therapeutics June 2015, 353 (3) 573-581; DOI: https://doi.org/10.1124/jpet.115.223107

  2. Liang, Cai-li

    1. A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor γ with Excellent Effect on Insulin Resistance and Type 2 Diabetes
      Hui-juan Liu, Cheng-yu Zhang, Fei Song, Ting Xiao, Jing Meng, Qiang Zhang, Cai-li Liang, Shan Li, Jing Wang, Bo Zhang, Yan-rong Liu, Tao Sun and Hong-gang Zhou
      Journal of Pharmacology and Experimental Therapeutics June 2015, 353 (3) 573-581; DOI: https://doi.org/10.1124/jpet.115.223107

  3. Liang, Guang

    1. Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2
      Yi Wang, Xiaoou Shan, Yuanrong Dai, Lili Jiang, Gaozhi Chen, Yali Zhang, Zhe Wang, Lili Dong, Jianzhang Wu, Guilong Guo and Guang Liang
      Journal of Pharmacology and Experimental Therapeutics June 2015, 353 (3) 539-550; DOI: https://doi.org/10.1124/jpet.115.222570

  4. Liles, John T.

    1. Ranolazine Reduces Remodeling of the Right Ventricle and Provoked Arrhythmias in Rats with Pulmonary Hypertension
      John T. Liles, Kirsten Hoyer, Jason Oliver, Liguo Chi, Arvinder K. Dhalla and Luiz Belardinelli
      Journal of Pharmacology and Experimental Therapeutics June 2015, 353 (3) 480-489; DOI: https://doi.org/10.1124/jpet.114.221861

  5. Lin, Yingfeng

    1. Endothelin Receptor B Protects Granulocyte Macrophage Colony-Stimulating Factor mRNA from Degradation
      David Jungck, Jürgen Knobloch, Sandra Körber, Yingfeng Lin, Jürgen Konradi, Sarah Yanik, Erich Stoelben and Andrea Koch
      Journal of Pharmacology and Experimental Therapeutics June 2015, 353 (3) 564-572; DOI: https://doi.org/10.1124/jpet.114.215822

  6. Liu, Hui-juan

    1. A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor γ with Excellent Effect on Insulin Resistance and Type 2 Diabetes
      Hui-juan Liu, Cheng-yu Zhang, Fei Song, Ting Xiao, Jing Meng, Qiang Zhang, Cai-li Liang, Shan Li, Jing Wang, Bo Zhang, Yan-rong Liu, Tao Sun and Hong-gang Zhou
      Journal of Pharmacology and Experimental Therapeutics June 2015, 353 (3) 573-581; DOI: https://doi.org/10.1124/jpet.115.223107

  7. Liu, Yan-rong

    1. A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor γ with Excellent Effect on Insulin Resistance and Type 2 Diabetes
      Hui-juan Liu, Cheng-yu Zhang, Fei Song, Ting Xiao, Jing Meng, Qiang Zhang, Cai-li Liang, Shan Li, Jing Wang, Bo Zhang, Yan-rong Liu, Tao Sun and Hong-gang Zhou
      Journal of Pharmacology and Experimental Therapeutics June 2015, 353 (3) 573-581; DOI: https://doi.org/10.1124/jpet.115.223107

  8. Lyakhov, Sergey A.

    1. Anti-Inflammatory Effects and Joint Protection in Collagen-Induced Arthritis after Treatment with IQ-1S, a Selective c-Jun N-Terminal Kinase Inhibitor
      Igor A. Schepetkin, Liliya N. Kirpotina, Deepa Hammaker, Irina Kochetkova, Andrei I. Khlebnikov, Sergey A. Lyakhov, Gary S. Firestein and Mark T. Quinn
      Journal of Pharmacology and Experimental Therapeutics June 2015, 353 (3) 505-516; DOI: https://doi.org/10.1124/jpet.114.220251
Back to top

In this issue

Advertisement